Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-024396)

Filing Details

Accession Number:: 0001209191-11-024396
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-04-26 15:41:44
Reporting Period:: 2011-04-25

Filing Date:: 2011-04-26
Accepted Time:: 2011-04-26 15:41:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1256126	Peter Mueller	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139	Evp, Global R&D, Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-04-25	12,500	$16.32	146,235	No	4	M	Direct
Common Stock	Disposition	2011-04-25	12,500	$50.00	133,735	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2011-04-25	12,500	$0.00	12,500	$16.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
100,000		2013-07-15	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,150	Indirect	401(k)

Footnotes

Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Fully vested.